A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
Clinical trial NCT06115902 · COMPLETED
Trial details
- NCT number
- NCT06115902
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2025-02-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.